Earli Biotech

Funding, team structure (meet the founders), partners and clients

undefined logo
Market - Biotech
Description - Earli is forcing cancer to reveal itself and its exact location, at an early stage, when the chances of a cure are drastically higher. Instead of searching for biomarkers sometimes naturally shed by the cancer – and sometimes not – Earli’s compound is injected in the body and forces cancer cells to produce a non-human, synthetic biomarker that makes very small tumors visible in a PET scan, in blood, in breath, or in urine. It is called a Synthetic Biopsy.


Founder Cyriac Roeding